Literature DB >> 15291751

Requirement for G proteins in insulin-like growth factor-I-induced growth of prostate cells.

T Lyons-Darden1, Y Daaka.   

Abstract

Elevated levels of IGF-I in the circulation are associated with increased risk for the development of prostate cancer in men, and transgenic expression of human IGF-I in mouse epithelial prostate cells results in spontaneous prostate tumorigenesis. Little, however, is known about the mechanisms involved in the IGF-I-regulated growth of prostate cells. Here, we have demonstrated that treatment with IGF-I induces the activation of the mitogenic extracellular signal-regulated kinase (ERK) pathway and the growth of human prostate cells. Stimulation with IGF-I also promoted the tyrosine phosphorylation of epidermal growth factor receptor (EGFR). Signal relay from IGF-I to ERK requires heterotrimeric G proteins and EGFR; inhibition of Gi/o protein activation by pertussis toxin, or EGFR by tyrphostin AG1478 obliterated the ability of IGF-I to promote ERK activation. Further, treatment with pertussis toxin inhibited the IGF-I-mediated prostate cell growth. These data demonstrated the requirement of heterotrimeric G proteins in IGF-I-regulated prostate cell growth and suggest the potential utility of the G proteins as effective drug targets to combat this common cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291751     DOI: 10.1677/jme.0.0330165

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  2 in total

1.  Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation.

Authors:  Young-Lai Cho; Sung-Mo Hur; Ji-Yoon Kim; Ji-Hee Kim; Dong-Keon Lee; Jongeon Choe; Moo-Ho Won; Kwon-Soo Ha; Dooil Jeoung; Sanghwa Han; Sungwoo Ryoo; Hansoo Lee; Jeong-Ki Min; Young-Guen Kwon; Dong-Hyun Kim; Young-Myeong Kim
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

2.  Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

Authors:  Kasem Nithipatikom; Marilyn A Isbell; Michael P Endsley; Jeffrey E Woodliff; William B Campbell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-12-15       Impact factor: 3.072

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.